Episode Details
Back to EpisodesFenebrutinib Promises MS Breakthrough, Weather Triggers Tough Pain Days, Oregon Nanoagent Eradicates Tumors Safely, Brain Signals Drive Overeating, and more...
Published 7 months ago
Description
(0:10): Genentech's Fenebrutinib Shows Promising Results as Potential First Oral BTK Inhibitor for MS
(2:14): University Study Links Weather to Arthritis Pain, Predicts 'Tougher Pain Days' with Low-Pressure Systems
(4:10): Oregon State's Iron-Based Nanoagent Shows Promise in Tumor Eradication Without Toxicity
(5:50): Study Reveals Brain's Hidden Signals Fuel Overeating Despite Fullness, Highlighting Obesity Challenges
(7:21): New Study Uncovers Brain's Role in Chronic Pain and Anxiety, Reveals Potential Treatment Target
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Is the cold weather affecting my arthritis? - PA Media : PA Media
(2:14): University Study Links Weather to Arthritis Pain, Predicts 'Tougher Pain Days' with Low-Pressure Systems
(4:10): Oregon State's Iron-Based Nanoagent Shows Promise in Tumor Eradication Without Toxicity
(5:50): Study Reveals Brain's Hidden Signals Fuel Overeating Despite Fullness, Highlighting Obesity Challenges
(7:21): New Study Uncovers Brain's Role in Chronic Pain and Anxiety, Reveals Potential Treatment Target
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Is the cold weather affecting my arthritis? - PA Media : PA Media